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Background: In an era of a growing economic pressure for all health systems, the interest for “disinvestment” in
healthcare increased. In this context, evidence based approaches such as Health Technology Assessment (HTA) are
needed both to invest and to disinvest in health technologies. In order to investigate the extent of application of
HTA in this field, methodological projects/frameworks, case studies, dissemination initiatives on disinvestment
released by HTA agencies and organizations located in Europe were searched.
Methods: In July 2015, the websites of HTA agencies and organizations belonging to the European network for HTA
(EUnetHTA) and the International Network of Agencies for HTA (INAHTA) were accessed and searched through the use
of the term “disinvestment”. Retrieved deliverables were considered eligible if they reported methodological projects/
frameworks, case studies and dissemination initiatives focused on disinvestment in healthcare.
Results: 62 HTA agencies/organizations were accessed and eight methodological projects/frameworks, one case study
and one dissemination initiative were found starting from 2007. With respect to methodological projects/frameworks,
two were delivered in Austria, one in Italy, two in Spain and three in U.K. As for the case study and the dissemination
initiative, both came from U.K. The majority of deliverables were aimed at making an overview of existing
disinvestment approaches and at identifying challenges in their introduction.
Conclusions: Today, in a healthcare context characterized by resource scarcity and increasing service demand,
“disinvestment” from low-value services and reinvestment in high-value ones is a key strategy that may be supported
by HTA. The lack of evaluation of technologies in use, in particular at the end of their lifecycle, may be due to the scant
availability of frameworks and guidelines for identification and assessment of obsolete technologies that was shown by
our work. Although several projects were carried out in different countries, most remain constrained to the field of
research. Disinvestment is a relatively new concept in HTA that could pose challenges also from a methodological
point of view. To tackle these challenges, it is necessary to construct experiences at international level with the aim to
develop new methodological approaches to produce and grow evidence on disinvestment policies and practices.
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Around the world, every healthcare system is struggling
with rising costs and decision makers are endeavoring to
improve system efficiency and to ensure more effective
and safe access to care [1]. Therefore, getting high value
for patients must become a priority of healthcare deliv-
ery and this goal must belong to all stakeholders of the
system. Improving health value not only will benefit pa-
tients and providers but it will result in increased eco-
nomic sustainability of healthcare systems. To this aim,
it is necessary to pursue a patient-centered system [2]
and to foster the transformation to value-based health-
care within the organizations [3]. Therefore, a necessary
goal for modern healthcare systems is to disinvest from
low-value health technologies and to reinvest in high-
value ones. Health technologies include different kinds
of interventions (e.g. drugs, devices, medical and surgical
procedures, and healthcare organizational and manager-
ial systems) and represent a major driver of costs for
healthcare systems [4].
In this value-based context and in an era of a growing
economic pressure for all health systems, the interest for
“disinvestment” in healthcare increased. Disinvestment is
defined as “withdrawing health resources from any exist-
ing health care practices, procedures, technologies or
pharmaceuticals that are deemed to deliver little or no
health gain for their cost, and thus do not represent effi-
cient health resource allocation” [5]. These actions are
relevant for the sustainability of health systems because
of growing demand for healthcare services, increasing
availability of innovative and expensive health technolo-
gies and resource constraints. In order to tackle these
challenges, evidence based approaches, such as Health
Technology Assessment (HTA), are needed both to in-
vest and to disinvest in health technologies. HTA is de-
fined as “a multidisciplinary process that summarizes
information about the medical, social, economic and
ethical issues related to the use of a health technology in
a systematic, transparent, unbiased, robust manner. Its
aim is to inform the formulation of safe, effective, health
policies that are patient focused and seek to achieve best
value” [6]. HTA is an instrument supporting policy-
making and is widely applied to govern the drugs mar-
ket, particularly with respect to the introduction of new
medicines. Anyway, in the last few years, the interest in
the assessment of health technologies during their whole
life cycle increased. This also led to an increasing inter-
est into the application of HTA for disinvesting from lit-
tle or no benefit technologies [7]. This interest was
witnessed by the appearance of the topic of HTA for dis-
investment on PubMed in the last decade even though
with a low number of publications. Governmental and
non-governmental agencies and organizations are
entrusted to perform HTA at national and regional levelacross Europe and worldwide and are common forerun-
ners of the development of innovations in the field. In
order to investigate the extent of application of HTA in
disinvestment at the level of HTA agencies and organi-
zations located in Europe, methodological projects/
frameworks, case studies, dissemination initiatives on
disinvestment developed and released by the latter were
searched.
Methods
In July 2015, the websites of all the HTA agencies and
organizations belonging to the European network for
Health Technology Assessment (EUnetHTA) and the
International Network of Agencies for Health Technol-
ogy Assessment (INAHTA) were accessed and searched
entering the term “disinvestment” in the query box. Re-
trieved deliverables were considered eligible if they re-
ported methodological projects/frameworks, case
studies, dissemination initiatives focused on disinvest-
ment in healthcare and if they were published in English
or Italian. Deliverables were not considered eligible if
disinvestment was not the major topic or was addressed
only in a narrative way. The following data were col-
lected for each eligible deliverable: agency which re-
leased the deliverable; title of the methodological
project/framework, case study, dissemination initiative;
type of deliverable (i.e. position paper; methodological
document; project; article; workshop); status of the deliver-
able (i.e. ongoing; closed); year; working group/authors;
aim; field of application; methods; results and recommen-
dations; identification of potential objectives of disinvest-
ment. The screening process and the extraction of data
were performed independently by two researchers and
disagreements were solved through a consensus.
Results
Selection process and deliverables characteristics
A total number of 62 HTA agencies and organizations
were searched. Additional file 1: Table S1 shows the list.
All the websites were accessible except for three. Out
of 61 deliverables retrieved from the search, only ten
met the inclusion criteria. The ten deliverables were re-
leased from 2007 onwards. They generally were relied
on systematic reviews of the literature or questionnaires/
interviews or data collection and analysis. The majority
of deliverables were just aimed at making an overview of
existing approaches and to identify challenges that might
delay the introduction of disinvestment practices. Eight
of them may be classified as methodological projects/
frameworks [8–15], one as a case study [16] and one as
a dissemination initiative [17]. All of them were closed
at the time of the search except for one [10].
All the details regarding the ten deliverables are re-
ported in the Additional file 2: Table S2.
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As for methodological projects/frameworks, two were
delivered by the Ludwig Boltzmann Institute for Health
Technology Assessment (LBI-HTA) in Austria [8, 9], one
by the Agency for Regional Healthcare (Age.Na.S) in Italy
[10], two from Galician Agency for Health Technology
Assessment (AVALIA-T) [11] and Agència de Qualitat i
Avaluació Sanitàries de Catalunya (AQuAS) [12] in
Spain, one from the Evaluation, Trials and Studies Co-
ordinating Centre (NETSCC-NIHR) [13] and two from
the Healthcare Improvement Scotland (HIS) [14, 15] in
U.K.
Deliverables released by LBI-HTA (Austria) were two
systematic reviews. The first [8] was conducted in April
2011, assessing four scientific databases, websites of
HTA agencies and grey literature. Policies on disinvest-
ment from potentially obsolete technologies were the
focus of the research. The aim of the review was to offer
an ample overview of current disinvestment approaches
of some countries (England, Spain, Australia and
Canada) in order to identify the main challenges that
might delay introduction of disinvestment practices in
different settings and to develop recommendations for
the winning achievement of disinvestment strategies.
The overview of 31 articles showed that disinvestment
policies in England, Spain, Australia and Canada were
ongoing. The only country at a more advanced stage was
Spain that had an official methodological framework –
the Guideline for Not Funding existing health technologies.
Instead, in England, the National Institute for Health and
Care Excellence (NICE) was known issuing obligatory
disinvestment advices. In Australia and Canada a dynamic
debate on implementation of disinvestment policy was
found, but most of the projects were yet in a piloting phase
at regional level. A standard methodology of HTA for
disinvestment activities was identified in all organizations
studied. Nevertheless, there were not significant disinvest-
ment projects conducted, therefore authors concluded that
assessment of methods was not possible and future evi-
dence will serve in order to evaluate whether HTA meth-
odology for disinvestment is adequate or new methods
need to be built. Furthermore, dissemination of disinvest-
ment recommendations was considered decisive in all
countries. Conversely no explicit strategies for the applica-
tion of disinvestment results were proposed.
The second review of 2013 [9] was relied on five scien-
tific databases and was aimed to identify articles describ-
ing internationally developed and implemented models
for the recognition of unproductive interventions and
technologies. Websites of HTA agencies, Google and
relevant journals were hand searched to retrieve further
information. International experts were also involved
through a survey. On the basis of the results of the lit-
erature review (120 documents) and of questionnaires,eight implemented models were identified. The analysis
showed that there were commonalities concerning ob-
jectives, involvement of stakeholders and choice of target
groups. Most models identified ineffective interventions
and technologies using person- and literature-based in-
formation sources. Effectiveness, costs and benefit were
commonly applied as identification criteria. Physicians,
patients and HTA-researchers were involved. Outputs –
mostly HTA reports or lists – were generally distributed
via internet. Recommendations were implemented either
as compulsory guidelines or as non-binding information
for practitioners and other stakeholders. Nevertheless,
data to appraise the actual impact of models useful to
identify inefficient interventions and technologies were
missing.
Two HTA agencies/organizations, Age.Na.S and
AVALIA-T, were involved in delivering/proposing a
guide/approach to promote disinvestment. Nonetheless,
the project carried out by Age.Na.S started in 2012 and
was still ongoing at the time of the search, whereas the
one from AVALIA-T was closed.
The Italian project was concluded in 2015 and the re-
sults were recently published [10]. The aim of the pro-
ject was to develop a systematic and integrated approach
to identify obsolete health technologies and to plan the
implementation of new technologies in specific sectors
such as: an organized screening program for HPV cer-
vical cancer as a primary test, diagnostic imaging tech-
nologies, medical interventions and specific telemedicine
applications.
The emerged crucial aspects to be considered were the
following: the identification of the health needs, the ob-
solescence of technology, the involvement of profes-
sionals in the choices, the careful analysis of the
preventive context of both investment and disinvestment
and the monitoring of the effects of such choices. Con-
cerning these aspects, the project concluded with the
proposal of some concretely implementable tools repre-
sented by:
- a procedure for the identification by an expert panel
of interventions/procedures to be divested, starting from
the systematic review of the scientific literature;
- a computerized procedure to induce professionals to
identify discarded technologies according to a multi-
criteria decision model;
- the methodology to analyze a regional technological
park based on the assessment of the degree of obsoles-
cence and productivity and of potential innovation;
- the methodology of ex-post evaluation of investment
/ renewal interventions;
- guidelines on the implementation of an innovation
with the simultaneous disposal of the current alternative
(i.e. the DNA-HPV test as a primary test in the Italian
programs for cervical cancer screening).
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review until April 2009 in specialized databases [11],
with particular attention at webpages of different na-
tional HTA agencies and government bodies, for the
most part in the area of health services research. The re-
search was focused on obsolete health technologies, in-
cluding their limits and benefits. The produced guide
consisted of three different sections for identification,
prioritization and assessment of potentially obsolete
technologies. In the first section (identification), poten-
tial sources were established: 1) direct consultation of
medical literature; 2) consultation of new and rising
technology databases (i.e. EuroScan); 3) consultation of
systematic reviews published from scientific literature or
assessment agencies; and, 4) consultation with adminis-
trative offices that are upgraded to the National Health
System, hospital or regional service portfolios. After the
identification, the assessment agencies would apply a
standardized process to validate that the identified tech-
nology could be labeled as potentially obsolete and pri-
oritized. In the second chapter (prioritization), a specific
tool developed by AVALIA-T (PriTec tool) to prioritize
potentially obsolete health technologies for following as-
sessment was described. This tool consisted of three do-
mains (population/end-users; risk/benefit; costs,
organization and other implications) with a total of ten
criteria with specific weights. Furthermore, a free of
charge web application in Spanish and English was re-
leased (http://avalia-t.sergas.es/ or http://www.pritectools.
es/index.php?idioma=en or www.pritectools.es) enabling
up to 50 potentially obsolete health technologies to be
confronted and prioritized in order to be evaluated.
The final section proposed a pilot structure for the
assessment of potentially outdated technologies, with a
focus on the comparison of obsolete technologies with
alternative ones. To assess a potentially obsolete tech-
nology, an assessment document was planned, with
specific sections, focused on comparison of the bene-
fits (in terms of efficacy, safety, efficiency, costs and
other consequences) of the potentially obsolete versus
the proposed alternative technology.
The second project conducted in Spain by AQuAS
was published on Health Policy in 2013 [12]. In this
paper a frame of disinvestment strategies with a “value
for money” approach was proposed. Based on the expe-
riences of other countries, it reviewed the existing in-
struments for implementing this approach in the
Spanish National Health Service (SNS). Articulating the
proposed approach to “value for money” would require
three basic elements: (A) a regulatory framework, (B)
the ability to identify “low value” interventions and cre-
ate a guide on best practice, (C) the capacity to check
compliance to and effects of “enforced” guide. Although
these elements were present in the SNS from variousyears, their effective use in supporting a disinvestment
strategy met numerous obstacles. To overcome them,
the authors suggested to pool together experiences and
tools and to design a process following these steps: iden-
tifying a set of “low value” procedures and their more
cost-effective alternatives; mapping unjustifiable varia-
tions in the use of the selected procedures across the
SNS; conforming a web-based tool for customized vari-
ability analysis to take into account excess-use and
excess-costs of low value procedures in different
decision-making contexts.
Three deliverables were released in U.K. [13–15]. A
project was conducted by the NETSCC-NIHR in order
to develop a process allowing policy-makers identifying
existing procedures with uncertain appropriateness. The
other two projects were conducted by HIS in 2012 and
2013 respectively. The first work was carried out by a
group named Making Choices Spending Wisely- MaCS-
Wise, interested in investment and disinvestment and
belonging to the Scottish Health Technologies Group
(SHTG). The SHTG was established by the Scottish
Government Health Directorates (SGHD) and is an ad-
visory group that aims to offer support and assistance to
NHS boards when taking into consideration the intro-
duction of new technologies to NHSScotland assessed
by NICE and other HTA organizations in the U.K. and
internationally. The aim of the project was to review the
cost saving guidance and the ‘do not do’ recommenda-
tions released from NICE with regard to NHSScotland.
Recommendations were identified that were thought to be
easy to implement, likely to achieve cost savings and not
requiring additional investment. Specifically, the obtained
data indicated that NICE cost-saving recommendations
identified from cancer guidelines were current clinical
practice in the majority of NHS boards in Scotland.
The second project of HIS was undertaken to ascertain
the quantity and quality of the published evidence on
disinvestment. A search was carried out in the Cochrane
library, NHS Economic Evaluation Database and Med-
line to identify relevant documents published up to July
2012. This was supplemented by general web searching,
and backward and forward citation searching from in-
cluded references. Articles discussing or assessing ap-
proaches used to obtain or incorporate public opinion
when making any decisions relating to disinvestment
were selected. Only five articles discussed frameworks,
policies, processes or methods that were developed and
used to obtain, consider or incorporate the views of the
public during the disinvestment process. The review
showed that limited research was done to discover the
most suitable ways to involve the public in the decision-
making process on disinvestment. The majority of arti-
cles reported that additional effort was needed to allow
the public to increase and communicate informed views,
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decision-making process on disinvestment.Case studies and dissemination initiatives
In addition to the deliverables described, one case study
and one dissemination initiative were found on the topic
of disinvestment [16, 17]. The first one came from the
NICE [16] whereas the second from HIS [17] in U.K.
The case study was started in 2007 and it is still on-
going, while the dissemination initiative was conducted
in 2013.
The “do not do recommendations” database [16]
should be mentioned because it identifies and collects
all recommendations about NHS clinical practices to be
stopped completely or not used in daily practice. In fact,
the database included more than 90 recommendations
on different topics, among which: cancer care; blood and
immune system conditions; cardiovascular conditions;
diabetes and metabolic disorders; gastrointestinal dis-
eases; fertility, pregnancy and childbirth; genetic dis-
eases. Instead, the dissemination initiative was related to
the organization of a session on disinvestment in a
workshop realized by the SHTG team of HIS.Discussion
This work aimed to summarize the existing projects,
frameworks, case studies and initiatives on disinvestment
developed and released by HTA agencies and organiza-
tions located in Europe. Indeed, this review broadens the
knowledge of disinvestment activities in Europe collating
together not only projects in the field but also other
types of initiatives, such as real life applications or dis-
semination actions. A total number of 62 HTA agencies
and organizations were accessed and eight methodo-
logical projects/frameworks, one case study and one dis-
semination initiative were found starting from 2007.
With respect to methodological projects/frameworks,
two were delivered in Austria, one in Italy, two in Spain
and three in U.K. As for the case study and the dissem-
ination initiative, both came from U.K. The majority of
deliverables were aimed at making an overview of exist-
ing disinvestment approaches and to identify challenges
in their introduction. Two HTA agencies/organizations,
Age.Na.S and AVALIA-T, were involved in delivering/
proposing a guide/approach to promote disinvestment.
Age.Na.S and AVALIA-T frameworks both calls for the
involvement of multiple stakeholders and for the assess-
ment of available evidence in order to identify potential
obsolete technologies. Furthermore, both frameworks
rely on a multi-criteria decision analysis. Nevertheless,
AVALIA-T delivered a more structured framework en-
closing a tool for conducting the assessment. In particu-
lar, AVALIA-T proposed a framework for theidentification, prioritization and assessment of poten-
tially obsolete technologies used in healthcare.
Further deliverables assessed clinical practice, evaluat-
ing adherence to recommendations/guidelines and mak-
ing benchmarking. In particular, one project from HIS
assessed the adherence to NICE “do not do” recommen-
dations. The case study, the “do not do recommenda-
tions” database, is to be considered as a best example
identifying and collecting recommendations about clin-
ical practices to be discontinued or not used routinely.
Despite the great interest in the field of disinvestment in
healthcare, the identification of a “disinvestment frame-
work” at an international level that could be considered a
gold standard is a critical issue. Spain was the only country
that had a formal methodological framework but further
evidence is needed to assess its implementation and im-
pact also outside Spain. The attention paid to the topic by
the scientific community calls for the development of
frameworks for disinvestment and for their real-world im-
plementation as the main challenge.
Limited resources and increased demand for services
lead healthcare systems to do choices within bound bud-
gets underlying the need for prioritization. In fact, health
systems have to allow access to effective, safe and effi-
cient care. Priority setting may help health systems to
make decisions about services to be funded or not. In
this context, ‘disinvestment’ from low-value services and
reinvestment in high-value ones is a key strategy which
may be supported by HTA [18]. The issue of disinvest-
ment emerged from existing HTA activities and con-
cerns the assessment of technologies in their last phase
of lifecycle. The disinvestment supported by HTA meth-
odology started earning consideration as a policy ap-
proach for more efficient allocation of healthcare
resources [8]. However, many current technologies were
never assessed neither at their launch nor in their imple-
mentation phase. The lack of assessment, in particular at
the end of the lifecycle, may be due also to the scant
availability of frameworks and guidelines for identifica-
tion and assessment of obsolete technologies that was
shown by our work. Future research should address the
issue of developing and testing a standardized method
across European countries. In fact, although several pro-
jects were carried out in different countries, most re-
main constrained to the field of research. Important
initiatives, for example, were conducted outside Europe,
namely in Australia and New Zealand. A workshop, ti-
tled ‘Disinvestment is not a dirty word’, was held by the
Health Policy Advisory Committee on Technology
(HealthPACT) and supported by South Australia’s Chief
Medical Officer in Brisbane on 17 May 2013. It focused
on national and local disinvestment activities and the re-
lated challenges for physicians, health policy makers and
funders. A report was subsequently published [19]. The
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offer advice, as appropriate, as a standing committee of
the Australian Health Ministers’ Advisory Council’s Hos-
pitals Principal Committee; to support disinvestment op-
portunities at national and local levels; to supply a
national depository for disinvestment programs in order
to guarantee pertinent information to be disclosed and
to enable dialogue.
Nonetheless, detecting and eliminating potentially ob-
solete health technologies is a complex process that re-
quires inputs from all relevant stakeholders, including
the public and citizens, but coordinated efforts in edu-
cating all key stakeholders are necessary [18]. HTA plays
a key role in favoring an evidence-based approach to
pursue safety, quality, and appropriate allocation of re-
sources and it can support the disinvestment process in
healthcare [7].
Some limitations of this study need to be considered
when interpreting the findings. Firstly, although the
search was very wide in terms of sources, the websites of
all the HTA agencies and organizations were searched
using the nonspecific keyword “disinvestment”. More-
over, our search summarized methodological projects/
frameworks, case studies and dissemination initiatives of
HTA agencies and organizations but it excluded other
works in the scientific literature or present in other data-
bases. Hence, we found a rather small number of deliv-
erables in line with our criteria, and this clearly led to a
limited analysis of the European experiences on the field
of disinvestment. Nonetheless, this study represents the
first overview of HTA agencies and organizations activ-
ities trying to identify and describe the actions at Euro-
pean level on disinvestment in healthcare.
Conclusion
Disinvestment is a relatively new concept in HTA that
could pose challenges also from a methodological point
of view. To tackle these challenges, it is necessary to go
on with international experiences focused on rising
novel practical approaches to generate evidence and
tools for disinvestment policies and practices.
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